SP-CAT-071

RADA16 Peptide (RAD16-I)

US$674.70

In stock

Description

About RADA16 Peptide (RAD16-I)

RADA-16 or RAD16-I is a hydrogel forming peptide that is able to build a three-dimensional, water-rich network mimicking the properties of biological tissues. Formed through the self-assembly of RADA16, this hydrogel offers a wide range of applications in tissue engineering, drug delivery, wound healing, and regenerative medicine. For research use only, do not use in humans!

RADA16 Peptide (RAD16-I) - Specifications

Peptide sequence: Ac-RADARADARADARADA-NH2 (synthetic)
Amount: 20 mg net (AAA)
Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
Counterion: TFA
Delivery Format: Freeze-dried in plastic vial
MW (average): 1712.82
Application(s): Tissue engineering, Drug delivery
Condition(s)/Topic(s): Regenerative medicine
Standard Delivery Time: 2-5 days

Are you interested in other peptides or conjugation to a protein, nucleic acid or lipid? Choose your sequence, amount and purity with our Custom Peptide Synthesis services.

JPT’s Hydrogel Forming Peptides

Peptide-based hydrogels or peptide nanogels stand out due to their biocompatibility and biodegradability, which make them ideal for biomedical applications. These nanogels self-assemble in aqueous solutions without the need for gelators, cross-linkers, or mechanical stimulators, forming hydrogel scaffolds that closely resemble the architecture of the extracellular matrix (ECM). JPT Peptide Technologies has substantial, long-standing expertise in providing peptides in all formats, scales and modifications to the global scientific community. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.

Benefits of JPT’s Peptides

All peptides are made in Germany
Bulk orders or custom peptide synthesis upon request
Provision of freeze-dried aliquots for enhanced stability
Proven track record
Need the conjugated or modified peptide? Contact us!

References

References for RADA16 Peptide (RAD16-I)

References:
Read References with Specialty Peptides

Testimonial:
"Our group focuses on the in vitro study of risk factors in Alzheimer’s disease and, as we experienced that the in-house expression and production of the amyloid beta peptide is notoriously difficult, we are continuously dependent on a high quality supply of a large variety of these peptides from commercial source.We started our collaboration with JPT with their request to test a range of their peptides for the ability to produce toxic oligomers and fibrillar networks and were impressed by the rapid supply of a very wide range of high purity peptides with excellent fibril forming properties and toxicity profiles. JPT has shown real valuable know-how and experience in the field of peptide synthesis by their ability to generate high quality preparations of amyloid beta peptide variants which are known for their difficulty to handle."
Kerensa Broersen, Assistant Prof., Nanobiophysics Group, University of Twente, Enschede, The Netherlands

Testimonial:
Our group focuses on the in vitro study of risk factors in Alzheimer’s disease and, as we experienced that the in-house expression and production of the amyloid beta peptide is notoriously difficult, we are continuously dependent on a high quality supply of a large variety of these peptides from commercial source.We started our collaboration with JPT with their request to test a range of their peptides for the ability to produce toxic oligomers and fibrillar networks and were impressed by the rapid supply of a very wide range of high purity peptides with excellent fibril forming properties and toxicity profiles. JPT has shown real valuable know-how and experience in the field of peptide synthesis by their ability to generate high quality preparations of amyloid beta peptide variants which are known for their difficulty to handle.
Kerensa Broersen, Assistant Prof., Nanobiophysics Group, University of Twente, Enschede, The Netherlands

Properties

Properties of RADA16 Peptide (RAD16-I)

Amount:	20 mg net (AAA)
Application:	Drug delivery, Tissue engineering
Category:	Hydrogel Forming Peptides
Condition / Topic:	Regenerative medicine
Layout:	Freeze-dried in plastic vial
Organism:	Artificial
Protein Name:	Self-assembling peptide
Purity:	Trial Grade: each peptide purified to > 90% (HPLC/MS)
Quantification:	Yes